<DOC>
	<DOC>NCT00832650</DOC>
	<brief_summary>To assess the effect of fesoterodine 8 mg as compared to solifenacin 10 mg on colonic transit.</brief_summary>
	<brief_title>Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit</brief_title>
	<detailed_description />
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Healthy female subjects Evidence or history of clinically significant findings at screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Healthy; Fesoterodine; Solifenacin</keyword>
</DOC>